2519
правок
(Новая страница: «{| class="wikitable sortable" |- ! gene name ! number of publications ! description from UniProt |- |IFNAR2 |1 |Interferon alpha/beta receptor 2 precursor (IF...») |
Нет описания правки |
||
Строка 11: | Строка 11: | ||
|[[HCRT]] | |[[HCRT]] | ||
|1 | |1 | ||
| | |Orexin precursor (Hypocretin) (Hcrt) [Contains: Orexin-A (Hypocretin-1) (Hcrt1); Orexin-B (Hypocretin-2) (Hcrt2)] [OX] [PPORX] [PPOX] | ||
|- | |- | ||
|[[RRM2B]] | |[[RRM2B]] | ||
Строка 75: | Строка 75: | ||
|[[ANGPTL4]] | |[[ANGPTL4]] | ||
|1 | |1 | ||
| | |Angiopoietin-related protein 4 precursor (Angiopoietin-like protein 4) (Hepatic fibrinogen/angiopoietin-related protein) (HFARP) [Contains: ANGPTL4 N-terminal chain; ANGPTL4 C-terminal chain] [ARP4] [HFARP] [PGAR] [PP1158] [PSEC0166] [UNQ171/PRO197] | ||
|- | |- | ||
|[[SULT1E1]] | |[[SULT1E1]] | ||
Строка 91: | Строка 91: | ||
|[[TGFB3]] | |[[TGFB3]] | ||
|1 | |1 | ||
| | |Transforming growth factor beta-3 proprotein precursor [Contains: Latency-associated peptide (LAP); Transforming growth factor beta-3 (TGF-beta-3)] | ||
|- | |- | ||
|[[STAT3]] | |[[STAT3]] | ||
Строка 155: | Строка 155: | ||
|[[MAP1A]] | |[[MAP1A]] | ||
|2 | |2 | ||
| | |Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Contains: MAP1A heavy chain; MAP1 light chain LC2] [MAP1L] | ||
|- | |- | ||
|[[SOX17]] | |[[SOX17]] | ||
Строка 175: | Строка 175: | ||
|[[TNFSF15]] | |[[TNFSF15]] | ||
|1 | |1 | ||
| | |Tumor necrosis factor ligand superfamily member 15 (TNF ligand-related molecule 1) (Vascular endothelial cell growth inhibitor) [Contains: Tumor necrosis factor ligand superfamily member 15, membrane form; Tumor necrosis factor ligand superfamily member 15, secreted form] [TL1] [VEGI] | ||
|- | |- | ||
|[[FAR2]] | |[[FAR2]] | ||
Строка 219: | Строка 219: | ||
|[[HSD3B2]] | |[[HSD3B2]] | ||
|2 | |2 | ||
| | |3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II) (3-beta-HSD II) (3-beta-HSD adrenal and gonadal type) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)] [HSDB3B] | ||
|- | |- | ||
|[[ATG9A]] | |[[ATG9A]] | ||
Строка 247: | Строка 247: | ||
|[[EDN1]] | |[[EDN1]] | ||
|1 | |1 | ||
| | |Endothelin-1 precursor (Preproendothelin-1) (PPET1) [Contains: Endothelin-1 (ET-1); Big endothelin-1] | ||
|- | |- | ||
|[[IGFBP3]] | |[[IGFBP3]] | ||
Строка 323: | Строка 323: | ||
|[[RET]] | |[[RET]] | ||
|12 | |12 | ||
| | |Proto-oncogene tyrosine-protein kinase receptor Ret precursor (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Contains: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] [CDHF12] [CDHR16] [PTC] [RET51] | ||
|- | |- | ||
|[[RS1]] | |[[RS1]] | ||
Строка 355: | Строка 355: | ||
|[[OAT]] | |[[OAT]] | ||
|2 | |2 | ||
| | |Ornithine aminotransferase, mitochondrial precursor (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Contains: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form] | ||
|- | |- | ||
|[[AOX1]] | |[[AOX1]] | ||
Строка 383: | Строка 383: | ||
|[[LRP1]] | |[[LRP1]] | ||
|5 | |5 | ||
| | |Prolow-density lipoprotein receptor-related protein 1 precursor (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD91 antigen) [Contains: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] [A2MR] [APR] | ||
|- | |- | ||
|[[MAPT]] | |[[MAPT]] | ||
Строка 507: | Строка 507: | ||
|[[C4B]] | |[[C4B]] | ||
|1 | |1 | ||
| | |Complement C4-B precursor (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Contains: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain] [CO4] [CPAMD3] | ||
|- | |- | ||
|[[GNRH1]] | |[[GNRH1]] | ||
|2 | |2 | ||
| | |Progonadoliberin-1 precursor (Progonadoliberin I) [Contains: Gonadoliberin-1 (Gonadoliberin I) (Gonadorelin) (Gonadotropin-releasing hormone I) (GnRH-I) (Luliberin I) (Luteinizing hormone-releasing hormone I) (LH-RH I); GnRH-associated peptide 1 (GnRH-associated peptide I)] [GNRH] [GRH] [LHRH] | ||
|- | |- | ||
|[[TNFRSF11B]] | |[[TNFRSF11B]] | ||
Строка 527: | Строка 527: | ||
|[[FASN]] | |[[FASN]] | ||
|2 | |2 | ||
| | |Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] [FAS] | ||
|- | |- | ||
|[[TLR1]] | |[[TLR1]] | ||
Строка 691: | Строка 691: | ||
|[[IGF1R]] | |[[IGF1R]] | ||
|14 | |14 | ||
| | |Insulin-like growth factor 1 receptor precursor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD221 antigen) [Contains: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] | ||
|- | |- | ||
|[[DCTN1]] | |[[DCTN1]] | ||
Строка 759: | Строка 759: | ||
|[[OGG1]] | |[[OGG1]] | ||
|12 | |12 | ||
| | |N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (EC 4.2.99.18) (AP lyase)] [MMH] [MUTM] [OGH1] | ||
|- | |- | ||
|[[PXN]] | |[[PXN]] | ||
Строка 943: | Строка 943: | ||
|[[MPO]] | |[[MPO]] | ||
|15 | |15 | ||
| | |Myeloperoxidase precursor (EC 1.11.2.2) (MPO) [Contains: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain] | ||
|- | |- | ||
|[[RXFP1]] | |[[RXFP1]] | ||
Строка 1095: | Строка 1095: | ||
|[[COL17A1]] | |[[COL17A1]] | ||
|1 | |1 | ||
| | |Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Contains: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)] [BP180] [BPAG2] | ||
|- | |- | ||
|[[PPARG]] | |[[PPARG]] | ||
Строка 1195: | Строка 1195: | ||
|[[GLS]] | |[[GLS]] | ||
|4 | |4 | ||
| | |Glutaminase kidney isoform, mitochondrial precursor (EC 3.5.1.2) (GLS) (K-glutaminase) (L-glutamine amidohydrolase) [Contains: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain] [GLS1] [KIAA0838] | ||
|- | |- | ||
|[[CD86]] | |[[CD86]] | ||
Строка 1275: | Строка 1275: | ||
|[[RAG1]] | |[[RAG1]] | ||
|2 | |2 | ||
| | |V(D)J recombination-activating protein 1 (RAG-1) (RING finger protein 74) [Includes: Endonuclease RAG1 (EC 3.1.-.-); E3 ubiquitin-protein ligase RAG1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RAG1)] [RNF74] | ||
|- | |- | ||
|[[RPS11]] | |[[RPS11]] | ||
Строка 1283: | Строка 1283: | ||
|[[ITGA3]] | |[[ITGA3]] | ||
|1 | |1 | ||
| | |Integrin alpha-3 precursor (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD49c antigen) [Contains: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain] [MSK18] | ||
|- | |- | ||
|[[NRM]] | |[[NRM]] | ||
Строка 1291: | Строка 1291: | ||
|[[PRM2]] | |[[PRM2]] | ||
|1 | |1 | ||
| | |Protamine-2 (Sperm histone P2) (Sperm protamine P2) [Contains: Basic nuclear protein HPI1; Basic nuclear protein HPI2; Basic nuclear protein HPS1; Basic nuclear protein HPS2; Sperm histone HP4 (Sperm protamine P4); Sperm histone HP2 (Sperm protamine P2) (P2'); Sperm histone HP3 (P2'') (Sperm protamine P3)] | ||
|- | |- | ||
|[[DLAT]] | |[[DLAT]] | ||
Строка 1499: | Строка 1499: | ||
|[[FXN]] | |[[FXN]] | ||
|2 | |2 | ||
| | |Frataxin, mitochondrial precursor (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Contains: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN)] [FRDA] [X25] | ||
|- | |- | ||
|[[HNRNPF]] | |[[HNRNPF]] | ||
Строка 1539: | Строка 1539: | ||
|[[HSPG2]] | |[[HSPG2]] | ||
|1 | |1 | ||
| | |Basement membrane-specific heparan sulfate proteoglycan core protein precursor (HSPG) (Perlecan) (PLC) [Contains: Endorepellin; LG3 peptide] | ||
|- | |- | ||
|[[AHR]] | |[[AHR]] | ||
Строка 1567: | Строка 1567: | ||
|[[LTF]] | |[[LTF]] | ||
|2 | |2 | ||
| | |Lactotransferrin precursor (EC 3.4.21.-) (Lactoferrin) (Growth-inhibiting protein 12) (Talalactoferrin) [Contains: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C] [GIG12] [LF] | ||
|- | |- | ||
|[[EID3]] | |[[EID3]] | ||
Строка 1679: | Строка 1679: | ||
|[[CAD]] | |[[CAD]] | ||
|62 | |62 | ||
| | |CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] | ||
|- | |- | ||
|[[CYP1B1]] | |[[CYP1B1]] | ||
Строка 1711: | Строка 1711: | ||
|[[TGFB1]] | |[[TGFB1]] | ||
|3 | |3 | ||
| | |Transforming growth factor beta-1 proprotein precursor [Contains: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)] [TGFB] | ||
|- | |- | ||
|[[IFIT1]] | |[[IFIT1]] | ||
Строка 1911: | Строка 1911: | ||
|[[INSR]] | |[[INSR]] | ||
|1 | |1 | ||
| | |Insulin receptor precursor (EC 2.7.10.1) (IR) (CD220 antigen) [Contains: Insulin receptor subunit alpha; Insulin receptor subunit beta] | ||
|- | |- | ||
|[[CHRNE]] | |[[CHRNE]] | ||
Строка 2043: | Строка 2043: | ||
|[[APP]] | |[[APP]] | ||
|115 | |115 | ||
| | |Amyloid-beta precursor protein precursor (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Contains: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31] [A4] [AD1] | ||
|- | |- | ||
|[[HAS1]] | |[[HAS1]] | ||
Строка 2083: | Строка 2083: | ||
|[[CASP3]] | |[[CASP3]] | ||
|4 | |4 | ||
| | |Caspase-3 precursor (EC 3.4.22.56) (CASP-3) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Contains: Caspase-3 subunit p17; Caspase-3 subunit p12] [CPP32] | ||
|- | |- | ||
|[[CLEC4E]] | |[[CLEC4E]] | ||
Строка 2099: | Строка 2099: | ||
|[[PROC]] | |[[PROC]] | ||
|5 | |5 | ||
| | |Vitamin K-dependent protein C precursor (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Contains: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide] | ||
|- | |- | ||
|[[FHL1]] | |[[FHL1]] | ||
Строка 2247: | Строка 2247: | ||
|[[STK3]] | |[[STK3]] | ||
|2 | |2 | ||
| | |Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Contains: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] [KRS1] [MST2] | ||
|- | |- | ||
|[[ORC1]] | |[[ORC1]] | ||
Строка 2287: | Строка 2287: | ||
|[[GGT1]] | |[[GGT1]] | ||
|1 | |1 | ||
| | |Glutathione hydrolase 1 proenzyme precursor (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (EC 2.3.2.2) (GGT 1) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD224 antigen) [Contains: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain] [GGT] | ||
|- | |- | ||
|[[CLU]] | |[[CLU]] | ||
|19 | |19 | ||
| | |Clusterin precursor (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Sulfated glycoprotein 2) (SGP-2) (Testosterone-repressed prostate message 2) (TRPM-2) [Contains: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)] [APOJ] [CLI] [KUB1] [AAG4] | ||
|- | |- | ||
|[[CDC25A]] | |[[CDC25A]] | ||
Строка 2371: | Строка 2371: | ||
|[[FGB]] | |[[FGB]] | ||
|1 | |1 | ||
| | |Fibrinogen beta chain precursor [Contains: Fibrinopeptide B; Fibrinogen beta chain] | ||
|- | |- | ||
|[[ABCC3]] | |[[ABCC3]] | ||
Строка 2391: | Строка 2391: | ||
|[[SI]] | |[[SI]] | ||
|69 | |69 | ||
| | |Sucrase-isomaltase, intestinal [Contains: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] | ||
|- | |- | ||
|[[TYR]] | |[[TYR]] | ||
Строка 2491: | Строка 2491: | ||
|[[CACNA2D1]] | |[[CACNA2D1]] | ||
|1 | |1 | ||
| | |Voltage-dependent calcium channel subunit alpha-2/delta-1 precursor (Voltage-gated calcium channel subunit alpha-2/delta-1) [Contains: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1] [CACNL2A] [CCHL2A] [MHS3] | ||
|- | |- | ||
|[[PCNA]] | |[[PCNA]] | ||
Строка 2731: | Строка 2731: | ||
|[[C2]] | |[[C2]] | ||
|51 | |51 | ||
| | |Complement C2 precursor (EC 3.4.21.43) (C3/C5 convertase) [Contains: Complement C2b fragment; Complement C2a fragment] | ||
|- | |- | ||
|[[RBM3]] | |[[RBM3]] | ||
Строка 2815: | Строка 2815: | ||
|[[NOTCH3]] | |[[NOTCH3]] | ||
|3 | |3 | ||
| | |Neurogenic locus notch homolog protein 3 precursor (Notch 3) [Contains: Notch 3 extracellular truncation; Notch 3 intracellular domain] | ||
|- | |- | ||
|[[NRXN3]] | |[[NRXN3]] | ||
Строка 2963: | Строка 2963: | ||
|[[F8]] | |[[F8]] | ||
|1 | |1 | ||
| | |Coagulation factor VIII precursor (Antihemophilic factor) (AHF) (Procoagulant component) [Contains: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain] [F8C] | ||
|- | |- | ||
|[[C5]] | |[[C5]] | ||
|26 | |26 | ||
| | |Complement C5 precursor (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Contains: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain] [CPAMD4] | ||
|- | |- | ||
|[[BNC1]] | |[[BNC1]] | ||
Строка 3083: | Строка 3083: | ||
|[[XBP1]] | |[[XBP1]] | ||
|10 | |10 | ||
| | |X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Contains: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form] [TREB5] [XBP2] | ||
|- | |- | ||
|[[CTLA4]] | |[[CTLA4]] | ||
Строка 3107: | Строка 3107: | ||
|[[PAK2]] | |[[PAK2]] | ||
|1 | |1 | ||
| | |Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Contains: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] | ||
|- | |- | ||
|[[PGK2]] | |[[PGK2]] | ||
Строка 3195: | Строка 3195: | ||
|[[CTSB]] | |[[CTSB]] | ||
|7 | |7 | ||
| | |Cathepsin B precursor (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Contains: Cathepsin B light chain; Cathepsin B heavy chain] [CPSB] | ||
|- | |- | ||
|[[FOXO3]] | |[[FOXO3]] | ||
Строка 3255: | Строка 3255: | ||
|[[TNFRSF1A]] | |[[TNFRSF1A]] | ||
|1 | |1 | ||
| | |Tumor necrosis factor receptor superfamily member 1A precursor (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD120a antigen) [Contains: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)] [TNFAR] [TNFR1] | ||
|- | |- | ||
|[[EFNB1]] | |[[EFNB1]] | ||
|1 | |1 | ||
| | |Ephrin-B1 precursor (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) [Contains: Ephrin-B1 C-terminal fragment (Ephrin-B1 CTF); Ephrin-B1 intracellular domain (Ephrin-B1 ICD)] [EFL3] [EPLG2] [LERK2] | ||
|- | |- | ||
|[[HLA-DRB5]] | |[[HLA-DRB5]] | ||
Строка 3367: | Строка 3367: | ||
|[[MST1]] | |[[MST1]] | ||
|3 | |3 | ||
| | |Hepatocyte growth factor-like protein precursor (Macrophage stimulatory protein) (Macrophage-stimulating protein) (MSP) [Contains: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain] [D3F15S2] [DNF15S2] [HGFL] | ||
|- | |- | ||
|[[NTHL1]] | |[[NTHL1]] | ||
Строка 3387: | Строка 3387: | ||
|[[CXCL8]] | |[[CXCL8]] | ||
|9 | |9 | ||
| | |Interleukin-8 precursor (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Contains: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)] [IL8] | ||
|- | |- | ||
|[[PIN1]] | |[[PIN1]] | ||
Строка 3515: | Строка 3515: | ||
|[[CAMP]] | |[[CAMP]] | ||
|1 | |1 | ||
| | |Cathelicidin antimicrobial peptide precursor (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Contains: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37] [CAP18] [FALL39] [HSD26] | ||
|- | |- | ||
|[[L1CAM]] | |[[L1CAM]] | ||
Строка 3543: | Строка 3543: | ||
|[[AVP]] | |[[AVP]] | ||
|9 | |9 | ||
| | |Vasopressin-neurophysin 2-copeptin precursor (AVP-NPII) [Contains: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin] [ARVP] [VP] | ||
|- | |- | ||
|[[NT5E]] | |[[NT5E]] | ||
Строка 3607: | Строка 3607: | ||
|[[TGFB2]] | |[[TGFB2]] | ||
|1 | |1 | ||
| | |Transforming growth factor beta-2 proprotein precursor (Cetermin) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) [Contains: Latency-associated peptide (LAP); Transforming growth factor beta-2 (TGF-beta-2)] | ||
|- | |- | ||
|[[TCF4]] | |[[TCF4]] | ||
Строка 3683: | Строка 3683: | ||
|[[INSL3]] | |[[INSL3]] | ||
|4 | |4 | ||
| | |Insulin-like 3 precursor (Leydig insulin-like peptide) (Ley-I-L) (Relaxin-like factor) [Contains: Insulin-like 3 B chain; Insulin-like 3 A chain] [RLF] [RLNL] | ||
|- | |- | ||
|[[CLEC3B]] | |[[CLEC3B]] | ||
Строка 3695: | Строка 3695: | ||
|[[CCL5]] | |[[CCL5]] | ||
|12 | |12 | ||
| | |C-C motif chemokine 5 precursor (EoCP) (Eosinophil chemotactic cytokine) (SIS-delta) (Small-inducible cytokine A5) (T cell-specific protein P228) (TCP228) (T-cell-specific protein RANTES) [Contains: RANTES(3-68); RANTES(4-68)] [D17S136E] [SCYA5] | ||
|- | |- | ||
|[[PDE3A]] | |[[PDE3A]] | ||
Строка 3819: | Строка 3819: | ||
|[[SPX]] | |[[SPX]] | ||
|1 | |1 | ||
| | |precursor (NPQ) (Neuropeptide Q) (Spexin hormone) [Contains: Spexin-1; Spexin-2 (NPQ 53-70)] [C12orf39] | ||
|- | |- | ||
|[[TLR3]] | |[[TLR3]] | ||
Строка 3927: | Строка 3927: | ||
|[[TNF]] | |[[TNF]] | ||
|524 | |524 | ||
| | |Tumor necrosis factor precursor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Contains: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] [TNFA] [TNFSF2] | ||
|- | |- | ||
|[[TRPV1]] | |[[TRPV1]] | ||
Строка 4027: | Строка 4027: | ||
|[[AGL]] | |[[AGL]] | ||
|1 | |1 | ||
| | |Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (EC 3.2.1.33) (Amylo-1,6-glucosidase) (Dextrin 6-alpha-D-glucosidase)] [GDE] | ||
|- | |- | ||
|[[IL13RA1]] | |[[IL13RA1]] | ||
Строка 4055: | Строка 4055: | ||
|[[MAP1B]] | |[[MAP1B]] | ||
|3 | |3 | ||
| | |Microtubule-associated protein 1B (MAP-1B) [Contains: MAP1B heavy chain; MAP1 light chain LC1] | ||
|- | |- | ||
|[[MGRN1]] | |[[MGRN1]] | ||
Строка 4079: | Строка 4079: | ||
|[[HADHA]] | |[[HADHA]] | ||
|1 | |1 | ||
| | |Trifunctional enzyme subunit alpha, mitochondrial precursor (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)] [HADH] | ||
|- | |- | ||
|[[TAL1]] | |[[TAL1]] | ||
Строка 4279: | Строка 4279: | ||
|[[CD14]] | |[[CD14]] | ||
|36 | |36 | ||
| | |Monocyte differentiation antigen CD14 precursor (Myeloid cell-specific leucine-rich glycoprotein) (CD14 antigen) [Contains: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form] | ||
|- | |- | ||
|[[MUC5AC]] | |[[MUC5AC]] | ||
Строка 4287: | Строка 4287: | ||
|[[FGA]] | |[[FGA]] | ||
|5 | |5 | ||
| | |Fibrinogen alpha chain precursor [Contains: Fibrinopeptide A; Fibrinogen alpha chain] | ||
|- | |- | ||
|[[ACP2]] | |[[ACP2]] | ||
Строка 4307: | Строка 4307: | ||
|[[CCK]] | |[[CCK]] | ||
|36 | |36 | ||
| | |Cholecystokinin precursor (CCK) [Contains: Cholecystokinin-58 (CCK58); Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39 (CCK39); Cholecystokinin-33 (CCK33); Cholecystokinin-25 (CCK25); Cholecystokinin-18 (CCK18); Cholecystokinin-12 (CCK12); Cholecystokinin-8 (CCK8); Cholecystokinin-7 (CCK7); Cholecystokinin-5 (CCK5)] | ||
|- | |- | ||
|[[CPQ]] | |[[CPQ]] | ||
Строка 4351: | Строка 4351: | ||
|[[CTSD]] | |[[CTSD]] | ||
|1 | |1 | ||
| | |Cathepsin D precursor (EC 3.4.23.5) [Contains: Cathepsin D light chain; Cathepsin D heavy chain] [CPSD] | ||
|- | |- | ||
|[[SKAP2]] | |[[SKAP2]] | ||
Строка 4443: | Строка 4443: | ||
|[[CCL20]] | |[[CCL20]] | ||
|6 | |6 | ||
| | |C-C motif chemokine 20 precursor (Beta-chemokine exodus-1) (CC chemokine LARC) (Liver and activation-regulated chemokine) (Macrophage inflammatory protein 3 alpha) (MIP-3-alpha) (Small-inducible cytokine A20) [Contains: CCL20(1-67); CCL20(1-64); CCL20(2-70)] [LARC] [MIP3A] [SCYA20] | ||
|- | |- | ||
|[[ESCO1]] | |[[ESCO1]] | ||
Строка 4495: | Строка 4495: | ||
|[[UAP1]] | |[[UAP1]] | ||
|1 | |1 | ||
| | |UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)] [SPAG2] | ||
|- | |- | ||
|[[KCNMB2]] | |[[KCNMB2]] | ||
Строка 4607: | Строка 4607: | ||
|[[IL1R2]] | |[[IL1R2]] | ||
|2 | |2 | ||
| | |Interleukin-1 receptor type 2 precursor (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD121b antigen) [Contains: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)] [IL1RB] | ||
|- | |- | ||
|[[CYP27B1]] | |[[CYP27B1]] | ||
Строка 4623: | Строка 4623: | ||
|[[PAPSS1]] | |[[PAPSS1]] | ||
|1 | |1 | ||
| | |Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)] [ATPSK1] [PAPSS] | ||
|- | |- | ||
|[[SHBG]] | |[[SHBG]] | ||
Строка 4631: | Строка 4631: | ||
|[[VGF]] | |[[VGF]] | ||
|2 | |2 | ||
| | |Neurosecretory protein VGF precursor [Contains: Neuroendocrine regulatory peptide-1 (NERP-1); Neuroendocrine regulatory peptide-2 (NERP-2); VGF-derived peptide TLQP-21; VGF-derived peptide TLQP-62; Antimicrobial peptide VGF[554-577]] | ||
|- | |- | ||
|[[CD48]] | |[[CD48]] | ||
Строка 4743: | Строка 4743: | ||
|[[CORT]] | |[[CORT]] | ||
|37 | |37 | ||
| | |Cortistatin precursor [Contains: Cortistatin-29; Cortistatin-17] [UNQ307/PRO350] | ||
|- | |- | ||
|[[AIDA]] | |[[AIDA]] | ||
Строка 4855: | Строка 4855: | ||
|[[EDA]] | |[[EDA]] | ||
|8 | |8 | ||
| | |Ectodysplasin-A (Ectodermal dysplasia protein) (EDA protein) [Contains: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form] [ED1] [EDA2] | ||
|- | |- | ||
|[[ARNTL]] | |[[ARNTL]] | ||
Строка 4871: | Строка 4871: | ||
|[[CILP]] | |[[CILP]] | ||
|1 | |1 | ||
| | |Cartilage intermediate layer protein 1 precursor (CILP-1) (Cartilage intermediate-layer protein) [Contains: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2] [UNQ602/PRO1188] | ||
|- | |- | ||
|[[HAX1]] | |[[HAX1]] | ||
Строка 4911: | Строка 4911: | ||
|[[PLAU]] | |[[PLAU]] | ||
|4 | |4 | ||
| | |Urokinase-type plasminogen activator precursor (EC 3.4.21.73) (U-plasminogen activator) (uPA) [Contains: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B] | ||
|- | |- | ||
|[[ENPEP]] | |[[ENPEP]] | ||
Строка 5039: | Строка 5039: | ||
|[[PFKFB3]] | |[[PFKFB3]] | ||
|2 | |2 | ||
| | |6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] | ||
|- | |- | ||
|[[GPR37]] | |[[GPR37]] | ||
Строка 5131: | Строка 5131: | ||
|[[CFLAR]] | |[[CFLAR]] | ||
|1 | |1 | ||
| | |CASP8 and FADD-like apoptosis regulator precursor (Caspase homolog) (CASH) (Caspase-eight-related protein) (Casper) (Caspase-like apoptosis regulatory protein) (CLARP) (Cellular FLICE-like inhibitory protein) (c-FLIP) (FADD-like antiapoptotic molecule 1) (FLAME-1) (Inhibitor of FLICE) (I-FLICE) (MACH-related inducer of toxicity) (MRIT) (Usurpin) [Contains: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12] [CASH] [CASP8AP1] [CLARP] [MRIT] | ||
|- | |- | ||
|[[UPRT]] | |[[UPRT]] | ||
Строка 5279: | Строка 5279: | ||
|[[VIP]] | |[[VIP]] | ||
|13 | |13 | ||
| | |VIP peptides precursor [Contains: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)] | ||
|- | |- | ||
|[[TSC2]] | |[[TSC2]] | ||
Строка 5307: | Строка 5307: | ||
|[[BID]] | |[[BID]] | ||
|5 | |5 | ||
| | |BH3-interacting domain death agonist (p22 BID) (BID) [Contains: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID)] | ||
|- | |- | ||
|[[NDRG1]] | |[[NDRG1]] | ||
Строка 5503: | Строка 5503: | ||
|[[DCD]] | |[[DCD]] | ||
|2 | |2 | ||
| | |Dermcidin precursor (EC 3.4.-.-) (Preproteolysin) [Contains: Survival-promoting peptide; DCD-1] [AIDD] [DSEP] | ||
|- | |- | ||
|[[HNRNPA1]] | |[[HNRNPA1]] | ||
Строка 5551: | Строка 5551: | ||
|[[C9]] | |[[C9]] | ||
|7 | |7 | ||
| | |Complement component C9 precursor [Contains: Complement component C9a; Complement component C9b] | ||
|- | |- | ||
|[[CD81]] | |[[CD81]] | ||
Строка 5611: | Строка 5611: | ||
|[[CASP7]] | |[[CASP7]] | ||
|1 | |1 | ||
| | |Caspase-7 precursor (EC 3.4.22.60) (CASP-7) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Contains: Caspase-7 subunit p20; Caspase-7 subunit p11] [MCH3] | ||
|- | |- | ||
|[[GDA]] | |[[GDA]] | ||
Строка 5703: | Строка 5703: | ||
|[[CDH1]] | |[[CDH1]] | ||
|2 | |2 | ||
| | |Cadherin-1 precursor (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD324 antigen) [Contains: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3] [CDHE] [UVO] | ||
|- | |- | ||
|[[BAG2]] | |[[BAG2]] | ||
Строка 5799: | Строка 5799: | ||
|[[PF4V1]] | |[[PF4V1]] | ||
|1 | |1 | ||
| | |Platelet factor 4 variant precursor (C-X-C motif chemokine 4 variant) (CXCL4L1) (PF4alt) (PF4var1) [Contains: Platelet factor 4 variant(4-74); Platelet factor 4 variant(5-74); Platelet factor 4 variant(6-74)] [CXCL4V1] [SCYB4V1] | ||
|- | |- | ||
|[[WNK4]] | |[[WNK4]] | ||
Строка 5859: | Строка 5859: | ||
|[[MUC1]] | |[[MUC1]] | ||
|1 | |1 | ||
| | |Mucin-1 precursor (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD227 antigen) [Contains: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)] [PUM] | ||
|- | |- | ||
|[[ATG4B]] | |[[ATG4B]] | ||
Строка 5899: | Строка 5899: | ||
|[[RBP4]] | |[[RBP4]] | ||
|4 | |4 | ||
| | |Retinol-binding protein 4 precursor (Plasma retinol-binding protein) (PRBP) (RBP) [Contains: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176)] [PRO2222] | ||
|- | |- | ||
|[[SAMD12]] | |[[SAMD12]] | ||
Строка 5939: | Строка 5939: | ||
|[[IDS]] | |[[IDS]] | ||
|11 | |11 | ||
| | |Iduronate 2-sulfatase precursor (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Contains: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] [SIDS] | ||
|- | |- | ||
|[[HTT]] | |[[HTT]] | ||
Строка 6031: | Строка 6031: | ||
|[[PAM]] | |[[PAM]] | ||
|10 | |10 | ||
| | |Peptidyl-glycine alpha-amidating monooxygenase precursor (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (EC 1.14.17.3) (PHM); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)] | ||
|- | |- | ||
|[[ALKBH1]] | |[[ALKBH1]] | ||
Строка 6075: | Строка 6075: | ||
|[[CFB]] | |[[CFB]] | ||
|3 | |3 | ||
| | |Complement factor B precursor (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Contains: Complement factor B Ba fragment; Complement factor B Bb fragment] [BF] [BFD] | ||
|- | |- | ||
|[[NMNAT1]] | |[[NMNAT1]] | ||
Строка 6199: | Строка 6199: | ||
|[[MMP9]] | |[[MMP9]] | ||
|20 | |20 | ||
| | |Matrix metalloproteinase-9 precursor (EC 3.4.24.35) (MMP-9) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Contains: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9] [CLG4B] | ||
|- | |- | ||
|[[UBTD1]] | |[[UBTD1]] | ||
Строка 6239: | Строка 6239: | ||
|[[FGF23]] | |[[FGF23]] | ||
|30 | |30 | ||
| | |Fibroblast growth factor 23 precursor (FGF-23) (Phosphatonin) (Tumor-derived hypophosphatemia-inducing factor) [Contains: Fibroblast growth factor 23 N-terminal peptide; Fibroblast growth factor 23 C-terminal peptide] [HYPF] [UNQ3027/PRO9828] | ||
|- | |- | ||
|[[NIN]] | |[[NIN]] | ||
Строка 6299: | Строка 6299: | ||
|[[GNRH2]] | |[[GNRH2]] | ||
|1 | |1 | ||
| | |Progonadoliberin-2 precursor (Progonadoliberin II) [Contains: Gonadoliberin-2 (Gonadoliberin II) (Gonadotropin-releasing hormone II) (GnRH II) (Luliberin II) (Luteinizing hormone-releasing hormone II) (LH-RH II); GnRH-associated peptide 2 (GnRH-associated peptide II)] | ||
|- | |- | ||
|[[ADNP]] | |[[ADNP]] | ||
Строка 6311: | Строка 6311: | ||
|[[CFI]] | |[[CFI]] | ||
|19 | |19 | ||
| | |Complement factor I precursor (EC 3.4.21.45) (C3B/C4B inactivator) [Contains: Complement factor I heavy chain; Complement factor I light chain] [IF] | ||
|- | |- | ||
|[[DDC]] | |[[DDC]] | ||
Строка 6343: | Строка 6343: | ||
|[[PAPSS2]] | |[[PAPSS2]] | ||
|2 | |2 | ||
| | |Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)] [ATPSK2] | ||
|- | |- | ||
|[[RPTOR]] | |[[RPTOR]] | ||
Строка 6507: | Строка 6507: | ||
|[[NPY]] | |[[NPY]] | ||
|28 | |28 | ||
| | |Pro-neuropeptide Y precursor [Contains: Neuropeptide Y (Neuropeptide tyrosine) (NPY); C-flanking peptide of NPY (CPON)] | ||
|- | |- | ||
|[[PIK3CB]] | |[[PIK3CB]] | ||
Строка 6575: | Строка 6575: | ||
|[[PLA2G4A]] | |[[PLA2G4A]] | ||
|1 | |1 | ||
| | |Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)] [CPLA2] [PLA2G4] | ||
|- | |- | ||
|[[CD3G]] | |[[CD3G]] | ||
Строка 6615: | Строка 6615: | ||
|[[HSD17B4]] | |[[HSD17B4]] | ||
|1 | |1 | ||
| | |Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Contains: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] [EDH17B4] [SDR8C1] | ||
|- | |- | ||
|[[ZRSR2]] | |[[ZRSR2]] | ||
Строка 6623: | Строка 6623: | ||
|[[CCL18]] | |[[CCL18]] | ||
|1 | |1 | ||
| | |C-C motif chemokine 18 precursor (Alternative macrophage activation-associated CC chemokine 1) (AMAC-1) (CC chemokine PARC) (Dendritic cell chemokine 1) (DC-CK1) (Macrophage inflammatory protein 4) (MIP-4) (Pulmonary and activation-regulated chemokine) (Small-inducible cytokine A18) [Contains: CCL18(1-68); CCL18(3-69); CCL18(4-69)] [AMAC1] [DCCK1] [MIP4] [PARC] [SCYA18] | ||
|- | |- | ||
|[[OLFML3]] | |[[OLFML3]] | ||
Строка 6671: | Строка 6671: | ||
|[[GRN]] | |[[GRN]] | ||
|14 | |14 | ||
| | |Progranulin precursor (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Contains: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] | ||
|- | |- | ||
|[[CD80]] | |[[CD80]] | ||
Строка 6695: | Строка 6695: | ||
|[[MAP1S]] | |[[MAP1S]] | ||
|2 | |2 | ||
| | |Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Contains: MAP1S heavy chain; MAP1S light chain] [BPY2IP1] [C19orf5] [MAP8] [VCY2IP1] | ||
|- | |- | ||
|[[MCM9]] | |[[MCM9]] | ||
Строка 6711: | Строка 6711: | ||
|[[CYB5R3]] | |[[CYB5R3]] | ||
|1 | |1 | ||
| | |NADH-cytochrome b5 reductase 3 (EC 1.6.2.2) (B5R) (Cytochrome b5 reductase) (Diaphorase-1) [Contains: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form] [DIA1] | ||
|- | |- | ||
|[[HMX1]] | |[[HMX1]] | ||
Строка 6739: | Строка 6739: | ||
|[[XDH]] | |[[XDH]] | ||
|2 | |2 | ||
| | |Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (EC 1.17.1.4) (XD); Xanthine oxidase (EC 1.17.3.2) (XO) (Xanthine oxidoreductase) (XOR)] [XDHA] | ||
|- | |- | ||
|[[DNMT1]] | |[[DNMT1]] | ||
Строка 6755: | Строка 6755: | ||
|[[IHH]] | |[[IHH]] | ||
|2 | |2 | ||
| | |Indian hedgehog protein precursor (IHH) (HHG-2) [Contains: Indian hedgehog protein N-product; Indian hedgehog protein C-product] | ||
|- | |- | ||
|[[UBC]] | |[[UBC]] | ||
Строка 6823: | Строка 6823: | ||
|[[CCL13]] | |[[CCL13]] | ||
|2 | |2 | ||
| | |C-C motif chemokine 13 precursor (CK-beta-10) (Monocyte chemoattractant protein 4) (Monocyte chemotactic protein 4) (MCP-4) (NCC-1) (Small-inducible cytokine A13) [Contains: C-C motif chemokine 13, long chain; C-C motif chemokine 13, medium chain; C-C motif chemokine 13, short chain] [MCP4] [NCC1] [SCYA13] | ||
|- | |- | ||
|[[PLXNA4]] | |[[PLXNA4]] | ||
Строка 6935: | Строка 6935: | ||
|[[ARSA]] | |[[ARSA]] | ||
|1 | |1 | ||
| | |Arylsulfatase A precursor (EC 3.1.6.8) (ASA) (Cerebroside-sulfatase) [Contains: Arylsulfatase A component B; Arylsulfatase A component C] | ||
|- | |- | ||
|[[PRKAA1]] | |[[PRKAA1]] | ||
Строка 7087: | Строка 7087: | ||
|[[CXCL5]] | |[[CXCL5]] | ||
|3 | |3 | ||
| | |C-X-C motif chemokine 5 precursor (ENA-78(1-78)) (Epithelial-derived neutrophil-activating protein 78) (Neutrophil-activating peptide ENA-78) (Small-inducible cytokine B5) [Contains: ENA-78(8-78); ENA-78(9-78)] [ENA78] [SCYB5] | ||
|- | |- | ||
|[[MEIS1]] | |[[MEIS1]] | ||
Строка 7171: | Строка 7171: | ||
|[[PLAT]] | |[[PLAT]] | ||
|1 | |1 | ||
| | |Tissue-type plasminogen activator precursor (EC 3.4.21.68) (t-PA) (t-plasminogen activator) (tPA) (Alteplase) (Reteplase) [Contains: Tissue-type plasminogen activator chain A; Tissue-type plasminogen activator chain B] | ||
|- | |- | ||
|[[PCSK9]] | |[[PCSK9]] | ||
Строка 7215: | Строка 7215: | ||
|[[PPY]] | |[[PPY]] | ||
|2 | |2 | ||
| | |Pancreatic prohormone precursor (Pancreatic polypeptide) (PP) (Obinepitide) [Contains: Pancreatic hormone (PH); Pancreatic icosapeptide (PI)] [PNP] | ||
|- | |- | ||
|[[RP1]] | |[[RP1]] | ||
Строка 7259: | Строка 7259: | ||
|[[NOTCH4]] | |[[NOTCH4]] | ||
|1 | |1 | ||
| | |Neurogenic locus notch homolog protein 4 precursor (Notch 4) (hNotch4) [Contains: Notch 4 extracellular truncation; Notch 4 intracellular domain] [INT3] | ||
|- | |- | ||
|[[CST3]] | |[[CST3]] | ||
Строка 7291: | Строка 7291: | ||
|[[GART]] | |[[GART]] | ||
|1 | |1 | ||
| | |Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)] [PGFT] [PRGS] | ||
|- | |- | ||
|[[AKR1C3]] | |[[AKR1C3]] | ||
Строка 7415: | Строка 7415: | ||
|[[NPPB]] | |[[NPPB]] | ||
|1 | |1 | ||
| | |Natriuretic peptides B precursor (Brain natriuretic factor prohormone) (preproBNP) (proBNP) (Gamma-brain natriuretic peptide) (Iso-ANP) [Contains: NT-proBNP (NT-pro-BNP) (NT-proBNP(1-76)); proBNP(3-108); Brain natriuretic peptide 32 (BNP(1-32)) (BNP-32) (Brain natriuretic peptide) (BNP); BNP(1-30); BNP(1-29); BNP(1-28); BNP(2-31); BNP(3-32) (des-SerPro-BNP) (proBNP(79-108)); BNP(3-30); BNP(3-29); Brain natriuretic peptide 29 (BNP(4-32)); BNP(4-31); BNP(4-30); BNP(4-29); BNP(4-27); BNP(5-32); BNP(5-31); BNP(5-29)] | ||
|- | |- | ||
|[[SERPINE1]] | |[[SERPINE1]] | ||
Строка 7491: | Строка 7491: | ||
|[[FN1]] | |[[FN1]] | ||
|2 | |2 | ||
| | |Fibronectin precursor (FN) (Cold-insoluble globulin) (CIG) [Contains: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3] [FN] | ||
|- | |- | ||
|[[KLF4]] | |[[KLF4]] | ||
Строка 7563: | Строка 7563: | ||
|[[INS]] | |[[INS]] | ||
|16 | |16 | ||
| | |Insulin precursor [Contains: Insulin B chain; Insulin A chain] | ||
|- | |- | ||
|[[SOX10]] | |[[SOX10]] | ||
Строка 7691: | Строка 7691: | ||
|[[BECN1]] | |[[BECN1]] | ||
|3 | |3 | ||
| | |Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Contains: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa] [GT197] | ||
|- | |- | ||
|[[RAD21]] | |[[RAD21]] | ||
Строка 7747: | Строка 7747: | ||
|[[F5]] | |[[F5]] | ||
|8 | |8 | ||
| | |Coagulation factor V precursor (Activated protein C cofactor) (Proaccelerin, labile factor) [Contains: Coagulation factor V heavy chain; Coagulation factor V light chain] | ||
|- | |- | ||
|[[FOXF1]] | |[[FOXF1]] | ||
Строка 7779: | Строка 7779: | ||
|[[ACR]] | |[[ACR]] | ||
|13 | |13 | ||
| | |Acrosin precursor (EC 3.4.21.10) [Contains: Acrosin light chain; Acrosin heavy chain] [ACRS] | ||
|- | |- | ||
|[[SEC23B]] | |[[SEC23B]] | ||
Строка 7859: | Строка 7859: | ||
|[[TMPRSS2]] | |[[TMPRSS2]] | ||
|2 | |2 | ||
| | |Transmembrane protease serine 2 precursor (EC 3.4.21.-) (Serine protease 10) [Contains: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain] [PRSS10] | ||
|- | |- | ||
|[[PENK]] | |[[PENK]] | ||
|2 | |2 | ||
| | |Proenkephalin-A precursor [Contains: Synenkephalin; Met-enkephalin (Opioid growth factor) (OGF); PENK(114-133); PENK(143-183); Met-enkephalin-Arg-Gly-Leu; Leu-enkephalin; PENK(237-258); Met-enkephalin-Arg-Phe] | ||
|- | |- | ||
|[[SLC25A1]] | |[[SLC25A1]] | ||
Строка 7891: | Строка 7891: | ||
|[[COL2A1]] | |[[COL2A1]] | ||
|2 | |2 | ||
| | |Collagen alpha-1(II) chain precursor (Alpha-1 type II collagen) [Contains: Collagen alpha-1(II) chain; Chondrocalcin] | ||
|- | |- | ||
|[[FGFBP1]] | |[[FGFBP1]] | ||
Строка 7943: | Строка 7943: | ||
|[[KISS1]] | |[[KISS1]] | ||
|4 | |4 | ||
| | |Metastasis-suppressor KiSS-1 precursor (Kisspeptin-1) [Contains: Metastin (Kisspeptin-54); Kisspeptin-14; Kisspeptin-13; Kisspeptin-10] [PP5098] | ||
|- | |- | ||
|[[SYT1]] | |[[SYT1]] | ||
Строка 7975: | Строка 7975: | ||
|[[ITM2B]] | |[[ITM2B]] | ||
|1 | |1 | ||
| | |Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Contains: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)] [BRI] [BRI2] | ||
|- | |- | ||
|[[CD160]] | |[[CD160]] | ||
Строка 8059: | Строка 8059: | ||
|[[CXCL1]] | |[[CXCL1]] | ||
|20 | |20 | ||
| | |Growth-regulated alpha protein precursor (C-X-C motif chemokine 1) (GRO-alpha(1-73)) (Melanoma growth stimulatory activity) (MGSA) (Neutrophil-activating protein 3) (NAP-3) [Contains: GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73)] [GRO] [GRO1] [GROA] [MGSA] [SCYB1] | ||
|- | |- | ||
|[[EMD]] | |[[EMD]] | ||
Строка 8071: | Строка 8071: | ||
|[[CTSL]] | |[[CTSL]] | ||
|2 | |2 | ||
| | |Procathepsin L precursor (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) [Contains: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain] [CTSL1] | ||
|- | |- | ||
|[[GRB2]] | |[[GRB2]] | ||
Строка 8087: | Строка 8087: | ||
|[[CILP2]] | |[[CILP2]] | ||
|1 | |1 | ||
| | |Cartilage intermediate layer protein 2 precursor (CILP-2) [Contains: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2] | ||
|- | |- | ||
|[[KLF14]] | |[[KLF14]] | ||
Строка 8115: | Строка 8115: | ||
|[[CASP1]] | |[[CASP1]] | ||
|1 | |1 | ||
| | |Caspase-1 precursor (EC 3.4.22.36) (CASP-1) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Contains: Caspase-1 subunit p20; Caspase-1 subunit p10] [IL1BC] [IL1BCE] | ||
|- | |- | ||
|[[HP]] | |[[HP]] | ||
|45 | |45 | ||
| | |Haptoglobin precursor (Zonulin) [Contains: Haptoglobin alpha chain; Haptoglobin beta chain] | ||
|- | |- | ||
|[[ATG7]] | |[[ATG7]] | ||
Строка 8171: | Строка 8171: | ||
|[[PSEN1]] | |[[PSEN1]] | ||
|7 | |7 | ||
| | |Presenilin-1 (EC 3.4.23.-) (PS-1) (Protein S182) [Contains: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)] [AD3] [PS1] [PSNL1] | ||
|- | |- | ||
|[[HMOX1]] | |[[HMOX1]] | ||
Строка 8347: | Строка 8347: | ||
|[[ADM]] | |[[ADM]] | ||
|10 | |10 | ||
| | |Pro-adrenomedullin precursor [Contains: Adrenomedullin (AM); Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)] [AM] | ||
|- | |- | ||
|[[OTX2]] | |[[OTX2]] | ||
Строка 8363: | Строка 8363: | ||
|[[C3]] | |[[C3]] | ||
|63 | |63 | ||
| | |Complement C3 precursor (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Contains: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2] [CPAMD1] | ||
|- | |- | ||
|[[NEIL3]] | |[[NEIL3]] | ||
Строка 8395: | Строка 8395: | ||
|[[C4A]] | |[[C4A]] | ||
|1 | |1 | ||
| | |Complement C4-A precursor (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Contains: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain] [CO4] [CPAMD2] | ||
|- | |- | ||
|[[CSF1]] | |[[CSF1]] | ||
Строка 8459: | Строка 8459: | ||
|[[FOXP3]] | |[[FOXP3]] | ||
|6 | |6 | ||
| | |Forkhead box protein P3 (Scurfin) [Contains: Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form] [IPEX] [JM2] | ||
|- | |- | ||
|[[F2]] | |[[F2]] | ||
|64 | |64 | ||
| | |Prothrombin precursor (EC 3.4.21.5) (Coagulation factor II) [Contains: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] | ||
|- | |- | ||
|[[NPC1]] | |[[NPC1]] | ||
Строка 8483: | Строка 8483: | ||
|[[PSEN2]] | |[[PSEN2]] | ||
|3 | |3 | ||
| | |Presenilin-2 (EC 3.4.23.-) (PS-2) (AD3LP) (AD5) (E5-1) (STM-2) [Contains: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit] [AD4] [PS2] [PSNL2] [STM2] | ||
|- | |- | ||
|[[ING1]] | |[[ING1]] | ||
Строка 8567: | Строка 8567: | ||
|[[F7]] | |[[F7]] | ||
|3 | |3 | ||
| | |Coagulation factor VII precursor (EC 3.4.21.21) (Proconvertin) (Serum prothrombin conversion accelerator) (SPCA) (Eptacog alfa) [Contains: Factor VII light chain; Factor VII heavy chain] | ||
|- | |- | ||
|[[NRF1]] | |[[NRF1]] | ||
Строка 8591: | Строка 8591: | ||
|[[MYOC]] | |[[MYOC]] | ||
|1 | |1 | ||
| | |Myocilin precursor (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Contains: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)] [GLC1A] [TIGR] | ||
|- | |- | ||
|[[CYP17A1]] | |[[CYP17A1]] | ||
Строка 8603: | Строка 8603: | ||
|[[CTSA]] | |[[CTSA]] | ||
|1 | |1 | ||
| | |Lysosomal protective protein precursor (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Contains: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain] [PPGB] | ||
|- | |- | ||
|[[CPT1C]] | |[[CPT1C]] | ||
Строка 8743: | Строка 8743: | ||
|[[GAST]] | |[[GAST]] | ||
|1 | |1 | ||
| | |Gastrin precursor [Contains: Gastrin-71 (Gastrin component I); Gastrin-52 (G52); Big gastrin (Gastrin component II) (Gastrin-34) (G34); Gastrin (Gastrin component III) (Gastrin-17) (G17); Gastrin-14 (G14); Gastrin-6 (G6)] [GAS] | ||
|- | |- | ||
|[[ITGA5]] | |[[ITGA5]] | ||
|1 | |1 | ||
| | |Integrin alpha-5 precursor (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD49e antigen) [Contains: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain] [FNRA] | ||
|- | |- | ||
|[[CAST]] | |[[CAST]] | ||
Строка 8767: | Строка 8767: | ||
|[[COL15A1]] | |[[COL15A1]] | ||
|1 | |1 | ||
| | |Collagen alpha-1(XV) chain precursor [Contains: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV)] | ||
|- | |- | ||
|[[ATF4]] | |[[ATF4]] | ||
Строка 8887: | Строка 8887: | ||
|[[POMC]] | |[[POMC]] | ||
|11 | |11 | ||
| | |Pro-opiomelanocortin precursor (POMC) (Corticotropin-lipotropin) [Contains: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone) (ACTH); Melanocyte-stimulating hormone alpha (Alpha-MSH) (Melanotropin alpha); Corticotropin-like intermediary peptide (CLIP); Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanocyte-stimulating hormone beta (Beta-MSH) (Melanotropin beta); Beta-endorphin; Met-enkephalin] | ||
|- | |- | ||
|[[MYLPF]] | |[[MYLPF]] | ||
Строка 8951: | Строка 8951: | ||
|[[ITGA2B]] | |[[ITGA2B]] | ||
|4 | |4 | ||
| | |Integrin alpha-IIb precursor (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD41 antigen) [Contains: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2] [GP2B] [ITGAB] | ||
|- | |- | ||
|[[NMB]] | |[[NMB]] | ||
|2 | |2 | ||
| | |Neuromedin-B precursor [Contains: Neuromedin-B-32; Neuromedin-B] | ||
|- | |- | ||
|[[ITPKB]] | |[[ITPKB]] | ||
Строка 9103: | Строка 9103: | ||
|[[CRYAA]] | |[[CRYAA]] | ||
|1 | |1 | ||
| | |Alpha-crystallin A chain (Heat shock protein beta-4) (HspB4) [Contains: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162)] [CRYA1] [HSPB4] | ||
|- | |- | ||
|[[ZNF367]] | |[[ZNF367]] | ||
Строка 9159: | Строка 9159: | ||
|[[IL33]] | |[[IL33]] | ||
|1 | |1 | ||
| | |Interleukin-33 precursor (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Contains: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)] [C9orf26] [IL1F11] [NFHEV] | ||
|- | |- | ||
|[[RELB]] | |[[RELB]] | ||
Строка 9187: | Строка 9187: | ||
|[[PRKCD]] | |[[PRKCD]] | ||
|1 | |1 | ||
| | |Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Contains: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] | ||
|- | |- | ||
|[[HAMP]] | |[[HAMP]] | ||
|2 | |2 | ||
| | |Hepcidin precursor (Liver-expressed antimicrobial peptide 1) (LEAP-1) (Putative liver tumor regressor) (PLTR) [Contains: Hepcidin-25 (Hepc25); Hepcidin-20 (Hepc20)] [HEPC] [LEAP1] [UNQ487/PRO1003] | ||
|- | |- | ||
|[[APOE]] | |[[APOE]] | ||
Строка 9211: | Строка 9211: | ||
|[[ACOX1]] | |[[ACOX1]] | ||
|4 | |4 | ||
| | |Peroxisomal acyl-coenzyme A oxidase 1 (EC 1.3.3.6) (AOX) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX) [Contains: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] [ACOX] | ||
|- | |- | ||
|[[ARMS2]] | |[[ARMS2]] | ||
Строка 9311: | Строка 9311: | ||
|[[SAA1]] | |[[SAA1]] | ||
|2 | |2 | ||
| | |Serum amyloid A-1 protein precursor (SAA) [Contains: Amyloid protein A (Amyloid fibril protein AA); Serum amyloid protein A(2-104); Serum amyloid protein A(3-104); Serum amyloid protein A(2-103); Serum amyloid protein A(2-102); Serum amyloid protein A(4-101)] | ||
|- | |- | ||
|[[DPT]] | |[[DPT]] | ||
Строка 9431: | Строка 9431: | ||
|[[NTS]] | |[[NTS]] | ||
|7 | |7 | ||
| | |Neurotensin/neuromedin N precursor [Contains: Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); Tail peptide] | ||
|- | |- | ||
|[[ISL1]] | |[[ISL1]] | ||
Строка 9459: | Строка 9459: | ||
|[[GNE]] | |[[GNE]] | ||
|3 | |3 | ||
| | |Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)] [GLCNE] | ||
|- | |- | ||
|[[TREM1]] | |[[TREM1]] | ||
Строка 9479: | Строка 9479: | ||
|[[HGF]] | |[[HGF]] | ||
|24 | |24 | ||
| | |Hepatocyte growth factor precursor (Hepatopoietin-A) (Scatter factor) (SF) [Contains: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain] [HPTA] | ||
|- | |- | ||
|[[PGF]] | |[[PGF]] | ||
Строка 9515: | Строка 9515: | ||
|[[NOTCH1]] | |[[NOTCH1]] | ||
|6 | |6 | ||
| | |Neurogenic locus notch homolog protein 1 precursor (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Contains: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] [TAN1] | ||
|- | |- | ||
|[[SIX4]] | |[[SIX4]] | ||
Строка 9591: | Строка 9591: | ||
|[[LOX]] | |[[LOX]] | ||
|15 | |15 | ||
| | |Protein-lysine 6-oxidase precursor (EC 1.4.3.13) (Lysyl oxidase) [Contains: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form] | ||
|- | |- | ||
|[[PPP2R1A]] | |[[PPP2R1A]] | ||
Строка 9615: | Строка 9615: | ||
|[[CASP5]] | |[[CASP5]] | ||
|1 | |1 | ||
| | |Caspase-5 precursor (EC 3.4.22.58) (CASP-5) (ICE(rel)-III) (Protease ICH-3) (Protease TY) [Contains: Caspase-5 subunit p20; Caspase-5 subunit p10] [ICH3] | ||
|- | |- | ||
|[[MS4A6E]] | |[[MS4A6E]] | ||
Строка 9819: | Строка 9819: | ||
|[[HPSE]] | |[[HPSE]] | ||
|1 | |1 | ||
| | |Heparanase precursor (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Contains: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit] [HEP] [HPA] [HPA1] [HPR1] [HPSE1] [HSE1] | ||
|- | |- | ||
|[[ITCH]] | |[[ITCH]] | ||
Строка 9927: | Строка 9927: | ||
|[[DSPP]] | |[[DSPP]] | ||
|1 | |1 | ||
| | |Dentin sialophosphoprotein precursor [Contains: Dentin phosphoprotein (Dentin phosphophoryn) (DPP); Dentin sialoprotein (DSP)] | ||
|- | |- | ||
|[[IL17RC]] | |[[IL17RC]] | ||
Строка 9971: | Строка 9971: | ||
|[[PTHLH]] | |[[PTHLH]] | ||
|1 | |1 | ||
| | |Parathyroid hormone-related protein precursor (PTH-rP) (PTHrP) (Parathyroid hormone-like protein) (PLP) [Contains: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139])] [PTHRP] | ||
|- | |- | ||
|[[SESN3]] | |[[SESN3]] | ||
Строка 10 047: | Строка 10 047: | ||
|[[AGA]] | |[[AGA]] | ||
|6 | |6 | ||
| | |N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase precursor (EC 3.5.1.26) (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Contains: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] | ||
|- | |- | ||
|[[TLR8]] | |[[TLR8]] | ||
Строка 10 067: | Строка 10 067: | ||
|[[APOA1]] | |[[APOA1]] | ||
|3 | |3 | ||
| | |Apolipoprotein A-I precursor (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Contains: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))] | ||
|- | |- | ||
|[[MICA]] | |[[MICA]] | ||
Строка 10 223: | Строка 10 223: | ||
|[[CXCL12]] | |[[CXCL12]] | ||
|14 | |14 | ||
| | |Stromal cell-derived factor 1 precursor (SDF-1) (hSDF-1) (C-X-C motif chemokine 12) (Intercrine reduced in hepatomas) (IRH) (hIRH) (Pre-B cell growth-stimulating factor) (PBSF) [Contains: SDF-1-beta(3-72); SDF-1-alpha(3-67)] [SDF1] [SDF1A] [SDF1B] | ||
|- | |- | ||
|[[BIN1]] | |[[BIN1]] | ||
Строка 10 355: | Строка 10 355: | ||
|[[SORCS2]] | |[[SORCS2]] | ||
|1 | |1 | ||
| | |VPS10 domain-containing receptor SorCS2 precursor [Contains: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain] [KIAA1329] | ||
|- | |- | ||
|[[MMP1]] | |[[MMP1]] | ||
|11 | |11 | ||
| | |Interstitial collagenase precursor (EC 3.4.24.7) (Fibroblast collagenase) (Matrix metalloproteinase-1) (MMP-1) [Contains: 22 kDa interstitial collagenase; 27 kDa interstitial collagenase] [CLG] | ||
|- | |- | ||
|[[UCP2]] | |[[UCP2]] | ||
Строка 10 523: | Строка 10 523: | ||
|[[DPP4]] | |[[DPP4]] | ||
|9 | |9 | ||
| | |Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD26 antigen) [Contains: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)] [ADCP2] [CD26] | ||
|- | |- | ||
|[[DHRS2]] | |[[DHRS2]] | ||
Строка 10 535: | Строка 10 535: | ||
|[[LCT]] | |[[LCT]] | ||
|3 | |3 | ||
| | |Lactase-phlorizin hydrolase precursor (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)] [LPH] | ||
|- | |- | ||
|[[DCT]] | |[[DCT]] | ||
Строка 10 735: | Строка 10 735: | ||
|[[GAL]] | |[[GAL]] | ||
|18 | |18 | ||
| | |Galanin peptides precursor [Contains: Galanin; Galanin message-associated peptide (GMAP)] [GAL1] [GALN] [GLNN] | ||
|- | |- | ||
|[[GPRC5C]] | |[[GPRC5C]] | ||
Строка 10 955: | Строка 10 955: | ||
|[[F9]] | |[[F9]] | ||
|3 | |3 | ||
| | |Coagulation factor IX precursor (EC 3.4.21.22) (Christmas factor) (Plasma thromboplastin component) (PTC) [Contains: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain] | ||
|- | |- | ||
|[[SST]] | |[[SST]] | ||
|19 | |19 | ||
| | |Somatostatin precursor (Growth hormone release-inhibiting factor) [Contains: Somatostatin-28; Somatostatin-14 (SST-14); Neuronostatin (NST)] | ||
|- | |- | ||
|[[CHAT]] | |[[CHAT]] | ||
Строка 11 151: | Строка 11 151: | ||
|[[SLIT2]] | |[[SLIT2]] | ||
|1 | |1 | ||
| | |Slit homolog 2 protein precursor (Slit-2) [Contains: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product] [SLIL3] | ||
|- | |- | ||
|[[LDB2]] | |[[LDB2]] | ||
Строка 11 255: | Строка 11 255: | ||
|[[CTSC]] | |[[CTSC]] | ||
|1 | |1 | ||
| | |Dipeptidyl peptidase 1 precursor (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Contains: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] [CPPI] | ||
|- | |- | ||
|[[PTPRC]] | |[[PTPRC]] | ||
Строка 11 263: | Строка 11 263: | ||
|[[NPW]] | |[[NPW]] | ||
|2 | |2 | ||
| | |Neuropeptide W precursor (Preproprotein L8) (hPPL8) [Contains: Neuropeptide W-23 (NPW23) (hL8); Neuropeptide W-30 (NPW30) (hL8C)] [PPL8] [PPNPW] | ||
|- | |- | ||
|[[NLRP6]] | |[[NLRP6]] | ||
Строка 11 427: | Строка 11 427: | ||
|[[GAA]] | |[[GAA]] | ||
|8 | |8 | ||
| | |Lysosomal alpha-glucosidase precursor (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Contains: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] | ||
|- | |- | ||
|[[RGS14]] | |[[RGS14]] | ||
Строка 11 443: | Строка 11 443: | ||
|[[AGT]] | |[[AGT]] | ||
|3 | |3 | ||
| | |Angiotensinogen precursor (Serpin A8) [Contains: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4] [SERPINA8] | ||
|- | |- | ||
|[[FCER1G]] | |[[FCER1G]] | ||
Строка 11 475: | Строка 11 475: | ||
|[[BFSP1]] | |[[BFSP1]] | ||
|1 | |1 | ||
| | |Filensin (Beaded filament structural protein 1) (Lens fiber cell beaded-filament structural protein CP 115) (CP115) (Lens intermediate filament-like heavy) (LIFL-H) [Contains: Filensin C-terminal fragment; Filensin N-terminal fragment] | ||
|- | |- | ||
|[[KAT6B]] | |[[KAT6B]] | ||
Строка 11 487: | Строка 11 487: | ||
|[[F12]] | |[[F12]] | ||
|1 | |1 | ||
| | |Coagulation factor XII precursor (EC 3.4.21.38) (Hageman factor) (HAF) [Contains: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2)] | ||
|- | |- | ||
|[[SMURF2]] | |[[SMURF2]] | ||
Строка 11 547: | Строка 11 547: | ||
|[[MLN]] | |[[MLN]] | ||
|5 | |5 | ||
| | |Promotilin precursor [Contains: Motilin; Motilin-associated peptide (MAP)] | ||
|- | |- | ||
|[[HK2]] | |[[HK2]] | ||
Строка 11 567: | Строка 11 567: | ||
|[[ITGA6]] | |[[ITGA6]] | ||
|1 | |1 | ||
| | |Integrin alpha-6 precursor (CD49 antigen-like family member F) (VLA-6) (CD49f antigen) [Contains: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)] | ||
|- | |- | ||
|[[TXNRD3]] | |[[TXNRD3]] | ||
Строка 11 731: | Строка 11 731: | ||
|[[F10]] | |[[F10]] | ||
|1 | |1 | ||
| | |Coagulation factor X precursor (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) [Contains: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain] | ||
|- | |- | ||
|[[DNM2]] | |[[DNM2]] | ||
Строка 11 739: | Строка 11 739: | ||
|[[PSAP]] | |[[PSAP]] | ||
|1 | |1 | ||
| | |Prosaposin precursor (Proactivator polypeptide) [Contains: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)] [GLBA] [SAP1] | ||
|- | |- | ||
|[[TRIM21]] | |[[TRIM21]] | ||
Строка 11 747: | Строка 11 747: | ||
|[[IGF2]] | |[[IGF2]] | ||
|5 | |5 | ||
| | |Insulin-like growth factor II precursor (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Contains: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin] [PP1446] | ||
|- | |- | ||
|[[TMEM119]] | |[[TMEM119]] |